Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 780-785, February 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uehara, Y.
Right arrow Articles by Mizuno, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uehara, Y.
Right arrow Articles by Mizuno, S.

Mechanism of Reversion of Rous Sarcoma Virus Transformation by Herbimycin A: Reduction of Total Phosphotyrosine Levels Due to Reduced Kinase Activity and Increased Turnover of p60v-src1

Yoshimasa Uehara2, Yuko Murakami, Yoshikazu Sugimoto and Satoshi Mizuno

Department of Antibiotics, The National Institute of Health, 2-10-35 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan [Y. U., Y. M., S. M.]; and Aging Process Research Laboratory (Frontier Research Program), Tsukuba Life Science Center, RIKEN, Koyadai, Tsukuba-shi Ibaraki 305, Japan [Y. S.]

We studied the mechanism of reversion of Rous sarcoma virus (RSV)-transformation by herbimycin A in a temperature-sensitive RSV-infected NRK cell line. Herbimycin reduced the total cellular phosphotyrosine level to 10% of the control value. Intracellular p60src kinase activity was reduced significantly within 3 h of herbimycin treatment, but recovered to approximately 50% of the control within 24 h, and the kinetics paralleled the decrease of the phosphorylation of a cellular target p36. Partial proteolytic phosphopeptide analysis of p60src revealed decreased phosphorylation of tyrosine 416 in the C-terminal half. Analysis of the steady state level of p60src indicated 30% decrease in src protein. Measurement of the rates of p60src synthesis and degradation showed that the decrease in the level was due to the accelerated degradation of src protein. Cycloheximide blocked this enhanced turnover of p60src, but did not block the herbimycin-induced inactivation of p60src kinase. Subcellular distribution and myristoylation of p60src protein were not altered. These results support the idea that RSV transformation is associated with elevated phosphotyrosine levels and indicate that inhibition of src kinase activity can reverse RSV-transformation by reducing cellular phosphotyrosine content.

1 This work was supported in part by a Grant-in-Aid for Cancer Research from the Japanese Ministry of Education, Science, and Culture.

2 To whom requests for reprints should be addressed.

Received 6/ 6/88. Revised 10/17/88. Accepted 11/ 7/88.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. D. Yorgin, S. D. Hartson, A. M. Fellah, B. T. Scroggins, W. Huang, E. Katsanis, J. M. Couchman, R. L. Matts, and L. Whitesell
Effects of Geldanamycin, a Heat-Shock Protein 90-Binding Agent, on T Cell Function and T Cell Nonreceptor Protein Tyrosine Kinases
J. Immunol., March 15, 2000; 164(6): 2915 - 2923.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Z. Lou, D. Jevremovic, D. D. Billadeau, and P. J. Leibson
A Balance between Positive and Negative Signals in Cytotoxic Lymphocytes Regulates the Polarization of Lipid Rafts during the Development of Cell-mediated Killing
J. Exp. Med., January 17, 2000; 191(2): 347 - 354.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
K. A. Lucas and J. T. Flynn
Signal transduction pathways involved in lipopolysaccharide-induced production of PGE2 by human microvascular endothelial cells
Innate Immunity, October 1, 1999; 5(5-6): 307 - 317.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
I. Fleming and R. Busse
Signal transduction of eNOS activation
Cardiovasc Res, August 15, 1999; 43(3): 532 - 541.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. E. Gardiner and S. E. D'Souza
Sequences within Fibrinogen and Intercellular Adhesion Molecule-1 (ICAM-1) Modulate Signals Required for Mitogenesis
J. Biol. Chem., April 23, 1999; 274(17): 11930 - 11936.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Muise-Helmericks, H. L. Grimes, A. Bellacosa, S. E. Malstrom, P. N. Tsichlis, and N. Rosen
Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway
J. Biol. Chem., November 6, 1998; 273(45): 29864 - 29872.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Dastych, D. Taub, M. C. Hardison, and D. D. Metcalfe
Tyrosine kinase-deficient Wv c-kit induces mast cell adhesion and chemotaxis
Am J Physiol Cell Physiol, November 1, 1998; 275(5): C1291 - C1299.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Luton, M. H. Cardone, M. Zhang, and K. E. Mostov
Role of Tyrosine Phosphorylation in Ligand-induced Regulation of Transcytosis of the Polymeric Ig Receptor
Mol. Biol. Cell, July 1, 1998; 9(7): 1787 - 1802.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Buckhaults, L. Chen, N. Fregien, and M. Pierce
Transcriptional Regulation of N-Acetylglucosaminyltransferase V by the src Oncogene
J. Biol. Chem., August 1, 1997; 272(31): 19575 - 19581.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. Mancini, B. O. Anderson, E. Caldwell, M. Sedghinasab, P. B. Paty, and D. M. Hockenbery
Mitochondrial Proliferation and Paradoxical Membrane Depolarization during Terminal Differentiation and Apoptosis in a Human Colon Carcinoma Cell Line
J. Cell Biol., July 28, 1997; 138(2): 449 - 469.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. G. Mimnaugh, C. Chavany, and L. Neckers
Polyubiquitination and Proteasomal Degradation of the p185c-erbB-2 Receptor Protein-tyrosine Kinase Induced by Geldanamycin
J. Biol. Chem., September 13, 1996; 271(37): 22796 - 22801.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Chavany, E. Mimnaugh, P. Miller, R. Bitton, P. Nguyen, J. Trepel, L. Whitesell, R. Schnur, J. D. Moyer, and L. Neckers
p185[IMAGE] Binds to GRP94 in Vivo
J. Biol. Chem., March 1, 1996; 271(9): 4974 - 4977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. M. Mahon and L. A. J. O'Neill
Studies into the Effect of the Tyrosine Kinase Inhibitor Herbimycin A on NF-kappaB Activation in T Lymphocytes
J. Biol. Chem., December 1, 1995; 270(48): 28557 - 28564.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. W. Schulte, M. V. Blagosklonny, C. Ingui, and L. Neckers
Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras Association
J. Biol. Chem., October 13, 1995; 270(41): 24585 - 24588.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. C. Ryan, W. W. Cruikshank, H. Kornfeld, T. L. Collins, and D. M. Center
The CD4-associated Tyrosine Kinase p56[IMAGE] Is Required for Lymphocyte Chemoattractant Factor-induced T Lymphocyte Migration
J. Biol. Chem., July 21, 1995; 270(29): 17081 - 17086.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Sepp-Lorenzino, Z. Ma, D. E. Lebwohl, A. Vinitsky, and N. Rosen
Herbimycin A Induces the 20 S Proteasome- and Ubiquitindependent Degradation of Receptor Tyrosine Kinases
J. Biol. Chem., July 14, 1995; 270(28): 16580 - 16587.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Chanmugam, L. Feng, S. Liou, B. C. Jang, M. Boudreau, G. Yu, J. H. Lee, H. J. Kwon, T. Beppu, M. Yoshida, et al.
Radicicol, a Protein Tyrosine Kinase Inhibitor, Suppresses the Expression of Mitogen-inducible Cyclooxygenase in Macrophages Stimulated with Lipopolysaccharide and in Experimental Glomerulonephritis
J. Biol. Chem., March 10, 1995; 270(10): 5418 - 5426.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
K Nakayama and D. Loh
No requirement for p56lck in the antigen-stimulated clonal deletion of thymocytes
Science, July 3, 1992; 257(5066): 94 - 96.
[Abstract] [PDF]


Home page
ScienceHome page
D. Cohen, Y Tani, H Tian, E Boone, L. Samelson, and H. Lane
Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1
Science, April 24, 1992; 256(5056): 542 - 545.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
L. Supino-Rosin, A. Yoshimura, Y. Yarden, Z. Elazar, and D. Neumann
Intracellular Retention and Degradation of the Epidermal Growth Factor Receptor, Two Distinct Processes Mediated by Benzoquinone Ansamycins
J. Biol. Chem., July 14, 2000; 275(29): 21850 - 21855.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Tikhomirov and G. Carpenter
Geldanamycin Induces ErbB-2 Degradation by Proteolytic Fragmentation
J. Biol. Chem., August 18, 2000; 275(34): 26625 - 26631.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Fuller and A. W. Cuthbert
Post-translational Disruption of the Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Molecular Chaperone Complex with Geldanamycin Stabilizes Delta F508 CFTR in the Rabbit Reticulocyte Lysate
J. Biol. Chem., November 22, 2000; 275(48): 37462 - 37468.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.